Expert Answers to Questions on PARP Inhibitor Combinations in Prostate Cancer
In this podcast episode, listen to Wassim Abida, MD, PhD; Joaquin Mateo, MD, PhD; and Charles J. Ryan, MD, as they answer questions on the use of PARP inhibitors and PARP inhibitor combinations for patients with prostate cancer.
Decera Clinical Education Oncology Podcast · Wassim Abida MD PhD, Joaquin Mateo MD PhD, Charles J Ryan MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Wassim Abida, MD, PhD; Joaquin Mateo, MD, PhD; and Charles J. Ryan, MD, answer questions from an audience of healthcare professionals on topics related to prostate cancer and PARP inhibition including:
- Germline and somatic mutation testing
- PARP inhibition in earlier stage disease
- PARP inhibitors plus AR-targeted therapy after progression on AR-targeted therapy
- PARP inhibition in taxane-sensitive patients
Presenters:
Wassim Abida, MD, PhD
Assistant Member
Assistant Attending Physician
Genitourinary Oncology Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Joaquin Mateo, MD, PhD
Group Leader
Prostate Cancer Translational Research
Vall d'Hebron Institute of Oncology
Attending Physician
Medical Oncology
Vall d'Hebron University Hospital
Barcelona, Spain
Charles J. Ryan, MD
Professor of Medicine
B.J. Kennedy Chair in Clinical Medical Oncology
Director, Division of Hematology, Oncology and Transplantation
Department of Medicine
University of Minnesota
Oncologist
Division of Hematology, Oncology and Transplantation
University of Minnesota Health Clinics and Surgery Center
Minneapolis, Minnesota
Link to full program, including downloadable slidesets, expert commentaries, and on-demand webcast:
https://bit.ly/3h1T5oR
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.